Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an important minimally invasive technique in lung cancer staging and diagnosis.
Aim A retrospective analysis of EBUS-TBNA performance in patients with suspected malignancy referred between November 2009 and December 2013 to a UK tertiary EBUS centre.
Methods We reviewed consecutive EBUS-TBNA cases with CT/PET positive mediastinal/hilar nodes detected in suspected malignancy. EBUS-TBNA was performed as previously documented [Medford A. et al. QJM 2009; 102:859–864]. No rapid on-site cytology was available.
Results 186 patients with suspected malignancy (intra/extrathoracic and lymphoproliferative) were referred for EBUS-TBNA. Mean age was 66(31–87) with a 3:2 male:female ratio. In this group the sensitivity of EBUS-TBNA was 95.5%, accuracy 96.2% and negative predictive value (NPV) 80.6%. The prevalence of malignancy was 84.4%.
159 patients (85%) were referred with suspected lung cancer. In this group the sensitivity of EBUS-TBNA was 94.7%, accuracy 95.6% and NPV 78.8%. The prevalence of lung cancer was 83.6%.
The performance of EBUS-TBNA by lung cancer stage was also analysed, (See Table).
Conclusions This study shows high EBUS-TBNA diagnostic accuracy for all lung cancer stages. The NPV may have been reduced by the high prevalence of lung cancer in our cohort.
The majority of EBUS-TBNA procedures were performed for radiological stage III-IV disease where confirmation of disease would select those suitable for palliative rather than radical treatment.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.